- Welcome, everyone, to Wednesday Nite @ the Lab.
My name is Fiona McNamara.
I'm a second year undergrad student here at the UW Madison.
I work for Tom Zinnen, who couldn't make it this evening.
We do this every Wednesday night, 50 times a year here at
the UW Biotechnology Center.
Tonight, it is my pleasure to introduce to you Nathan Sherer
from the Department of Oncology.
He is originally from Bismarck, North Dakota.
He went to Bismarck High School there, and then he went and got
his undergrad in Grinnell College, which is in Iowa.
Then he went to Yale to get his PhD,
and after that he post-docked in London, England, for five years
until he came to UW-Madison in 2011.
Tonight, he will be talking about
imaging live cells under viral attack.
Please join me in welcoming Nathan Sherer
to Wednesday Nite @ the Lab.
[applause]
- Thanks for being here tonight.
So yeah, my name is Nate, and I'm an Assistant Professor
affiliated with the Department of Oncology, which
is also known for the McArdle Laboratory for Cancer Research,
many of you will know.
And I have a joint appointment in the Institute for Molecular
Virology, which is on the other side of Henry Mall
in Robert Bock Laboratories on Linden Drive.
And tonight I'm going to tell you a little bit about--
It's mostly an excuse to try to--
You know, as the research goes on,
you start to lose touch with old things,
and I really wanted to sort of
go back through my old favorite movies and share them.
[laughter]
Because I miss them
and I don't get to talk about them all the time.
And hopefully, you known, through this I'll be able to,
you know, tell you a little bit about virology on this campus,
which is extraordinary.
I know Dave O'Connor was here a couple weeks ago
talking about Zika.
We have an almost second-to-none
community of virologists on this campus.
I'll tell you a little bit about why we care about viruses
and virus-host interactions and what we're trying to learn.
I'll tell you about how we've
gone about trying to build fluorescent viruses in cells
that we can image using live cell imaging.
So that's where the viral cellular attack
and interplay comes in.
And I'll sort of finish with, you know, what my vision
for the future in terms of what we can now do
in terms of sort of developing
a multi-variant, high content, multi-color imaging system
for trying to learn very comprehensive things
about how viruses act in cells,
and how they spread from one cell to another.
Okay, so viruses, why do we care?
Of course, viruses impact
the health of humans, animals, and plants.
So this is just kind of the last five years.
Things that have--
Many of these things have popped up.
Some of these things you know
that afflict us on a regular basis.
So we have seasonal flu, common colds,
all sorts of respiratory infections, stomach bugs,
chickenpox, herpes virus-type afflictions that are latent
and stick with us for lifetime,
come back and cause shingles.
Things like this.
I'm going to mostly talk about HIV/AIDS
because that's the focus of my laboratory.
HIV continues to be a massive problem and is still one of the,
I think, number six in terms of the top killers on the planet
despite all the progress we've made.
And then all these other guys which have been popping up
in recent years as the world population has grown,
as we've started to commingle
with new environments that we hadn't before, as viruses
continue to change and feel out new evolutionary space.
It turns out that some of them start to cause human diseases,
and that's, of course, what we saw with Ebola last year,
and then this year's hot topic of Zika.
Okay, so this is going to be kind of
the only dense text slide.
But just to run through, you know,
some global perspectives on what are some of the big viruses
that we worry about at present.
So, HIV currently infects
more than 34 million people on the planet.
There have been about 70 million infected
since it showed up in the late '70s.
And it still causes more than one million deaths per year
even though we now have pretty good drugs
that can control this infection.
Hepatitis B and C viruses are crazy.
More than 200 million people are infected at any one time.
And roughly one million deaths per year.
They both establish or can establish
lifelong chronic infections
that can lead to liver disease and cancers.
We're all full of different herpes viruses.
I had infection mononucleosis when I was in college
and a raging case of chickenpox when I was nine
caused by varicella-zoster.
A variety of herpes virus circulate in humans
and cause different diseases.
Birth defects, cancers, all sorts of issues.
Every year we're afflicted by new versions of influenza.
Roughly 250,000 deaths per year with pandemic potential.
So we're always very concerned about flu.
And rabies is always something that's just sort of terrified me
because it's almost universally fatal.
It's very rare in the United States
to now get a rabies infection but it does happen,
and it still, worldwide, leads to about 60,000 deaths per year.
And then, we have these emerging viruses.
So, each year, there seems to be
a hot new virus which is causing problems.
Fortunately, with the exception of Ebola in 2016, these viruses,
such as Ebola; Marburg, which are these Filoviruses;
SARS and MERS, which are members of the Coronavirus family;
Zika, which is all the rage at the moment
and is a Flavivirus.
And chikungunya is one that we haven't talked about too much,
but this is now prevalent in the Bahamas,
and it's also mosquito-borne like Zika.
And there's thought with climate change that
this will be one that will be quite prevalent,
especially in the south, over the next few years.
It causes a debilitating, long-lasting disease
that sort of resembles rheumatoid arthritis.
So, relatively few deaths from these emerging viruses,
but they keep coming.
They keep surprising us.
When I was just out of college,
I worked in a lab that studied Coronaviruses.
The virus we studied was called murine hepatitis virus.
It was the only virus, the Coronavirus,
that was known to cause disease.
And my boss couldn't get funding
because nobody cared about the mouse.
So after I left the lab, the NIH basically called her up
after SARS showed up because now we had a Coronavirus
that had showed up in people and was causing disease.
And they said, "How much money do you need?" [laughter]
So this is just to reinforce,
sort of, this need for basic research.
You know?
We need to study viruses even if we don't think they're important
because we really don't know what's coming in the pipeline.
And what will the future bring?
This is sort of an estimate.
It's a bit dated now.
This is almost 10 years old.
But, currently, there are at least 150 viruses
that infect humans that we know about.
And, you know, the prediction is, you know, over the next 10
years we'll probably identify upwards of 50 more.
And, again, as viruses fill evolutionary space
and encounter people
in different places and in different ways
than they have before, there's always potential
for a virus to find a new niche, cause a new disease.
Okay, so I'm just going to put on my ambassador hat
for a couple of minutes and talk about virology on campus.
So I'm affiliated with the Department of Oncology.
So that's cancer.
Why do we care about viruses?
Well, roughly 15% to 20% of human cancers
are caused by viruses.
So I named a couple of the viruses that cause cancers.
So different herpes viruses, hepatitis B and C viruses
are tightly linked to human cancers.
And the McArdle Laboratory, a famous building right behind us,
was really a hotbed for studying viruses that cause cancer and
understanding how they worked in a variety of animal systems.
And, as many of you know, McArdle has now
vacated this famous building and has moved to WIMR2.
And it's about the--
It's the 75th anniversary of the McArdle Laboratory.
And among many landmark discoveries
that have been made at McArdle, such as
Harold Rusch showing that UV light causes skin cancers,
the Millers showed how carcinogens lead to cancer,
Charles Heid--
I'll come back to Howard Temin.
But Charles Heidelberger discovered 5-FU.
This is a very potent anti-cancer therapeutic
that's still very commonly used in the clinic.
And Bill Dove, who's still very active in the department.
He's emeritus but continues several projects.
He developed the very first mouse model colorectal cancer,
suitable for drug testing.
But, in terms of viruses, this all went back to Howard Temin,
and this is another
fortuitous basic cancer research story
where Howard started his research studying
a chicken virus that caused a transmissible cancer
called Rous sarcoma.
And he was--
Over time, it was found that Rous sarcoma
was a virus that was part of the family called retroviruses.
These are viruses that are able to inject their genomes
into the cells, and we'll get into the details in a minute.
In 1975, Temin won the Nobel Prize for discovering
a reverse transcriptase, which is an enzyme.
The retroviruses are RNA viruses, they have RNA genomes,
but they convert that RNA genome into double-stranded DNA
that looks just like the DNA that's inside all of our cells.
And then it has a sophisticated mechanism for injecting that DNA
into the genome so that every single cell that gets infected
inherits a copy of that virus.
And Rous sarcoma virus had picked up a cellular gene
that it was carrying with it, which was called SAR kinase.
And any time it would infect a cell,
it would overexpress this kinase,
and it would cause the cells to replicate more quickly.
And that led to rapid cell proliferation
and the development of sarcomas in chickens.
He did all of his research, and the reason
that he won the Nobel Prize
is because this idea of reverse transcriptase through
what we call the central dogma of molecular biology
on his head, where in the 1950s we knew about DNA,
we knew that DNA encoded messenger RNAs,
and we knew that messenger RNAs were translated into proteins.
And that's sort of, you know, how cells worked.
And, from there on, you can make
all the enzymes and structures that you needed
in order to make a cell and then form a tissue
and then make an organism.
What Temin showed is that
this RNA virus could actually turn that mechanism on its head
and take an RNA, turn it back into DNA,
and then that DNA could be inserted into the genome.
And this discovery has been massively useful
for biotechnology because now we can take
messenger RNAs that we can isolate from cells
and turn them into DNA copies
that we can then store in the freezer and replicate
and use over and over.
And, perhaps most importantly, it turned out
when HIV came on the scene in the early '80s that
it was of the same family of viruses as that chicken virus.
And it required the same reverse transcriptase activity.
So what Howard had taught the world
about reverse transcriptase
led very quickly to the design of drugs
that turned out to be quite effective for inhibiting HIV.
So this discovery in a chicken virus ultimately led to,
you know, saving millions upon millions of lives.
So this is McArdle now.
Temin really devoted a lot of his energy in the '70s and '80s
to building a core of virologists in the department.
So our current chairman is Paul Lambert,
who studies human papillomavirus that causes cervical cancer.
At least in this slide we feature
Bill Sugden and Shannon Kenney and Rob Kalejta
and some other guy who study--
These guys study Epstein-Barr virus,
which causes lymphoma and mononucleosis.
Rob studies HCMV that causes birth defects.
It's another herpes virus and glioblastoma.
We have many other prominent virologists in the department,
and we interact with many fabulous other scientists
studying cell signaling mechanisms involved in cancer
and using genetic systems to try and determine
the origins of cancer.
And my other home
is the Institute for Molecular Virology.
So that's Bock that was I referring to earlier.
And there we're just all about viruses.
So this department was built by Paul Kaesberg,
who passed away in 2010, but was one of the world leaders
in understanding and characterizing
small RNA viruses,
and with a prominent role from Roland Rueckert,
who is one of the pioneers of
understanding structural biology using viral systems,
with an emphasis on Picornaviruses such as
polio and the rhinoviruses that cause the common cold.
So, at the IMV, we have many fabulous scientists.
Our chairman is Paul Friesen, who studies Baculovirus,
and Paul Moberg, who continues work on Picornaviruses.
Paul Ahlquist, who's one of the world's
most well renowned RNA virologists.
Rob and me, the three of us are also linked to McArdle
and the oncology department.
And I just wanted to set, you know, our mission
is to conduct research and do a lot of training at the IMV.
So we want to serve as the focus for virology on the campus.
We hold a weekly seminar series.
If anybody's interested, it's open in the biochem building
across the street at noon, all about viruses.
And we play a big role.
Every five years we host the American Society for Virology
meeting in Madison at the Monona Terrace.
And a couple weeks ago,
we hosted a Grandparents' University,
both out at McArdle and at the IMV.
Here's Ann Palmenberg teaching alumni and their grandkids
about viral structures.
Kelly Waters, a post doc in the department
teaching them about sequences.
So just an advertisement, if you're a grandparent, an alum,
a grandparent, or know of one, that should be pretty fun.
And I'll show this again at the end of the talk,
but these are just if you're interested
in virology on campus.
We also fantastic virologists in the department
in the Veterinary School,
the Department of Medical Microbiology, Immunology
and also in the pathology and laboratory medicine.
Okay, so HIV/AIDS, I mentioned
more than 35 million people infected globally.
We still have two million new cases per year
and more than one million deaths.
Despite huge efforts, we still do not have a vaccine for HIV.
We have one person
out of 70 million infected over the history of this pandemic
who we think is cured,
who has been off drugs for several years
with no recurrence.
That cure involved a stem cell transplant
and some very clever gene therapy type considerations.
So it's not a practical cure for anybody else.
We have great drugs since the mid-'90s that keep people alive
and to have a happy and healthy life.
But the problem remains getting everybody on drugs,
getting everybody adherent to their drug regiments,
keeping the drugs cheap enough and accessible.
So it's still going to be an enormous task to eradicate.
The current goals of the CDC, the NIH, and the WHO
and the UNAIDS are this 90-90-90 idea,
where 90% of the people who are infected with HIV
are going to know that they're infected.
It means more and more people have to be tested.
90% of those people who are positive are going to have
access to drugs and are going to stay on those drugs.
And of those 90% who are on drugs, they're going to have to
have their viral load suppressed.
If that works, the math looks really good that we could have
an AIDS-free generation over one to two generations.
So that's the current goal for between 2020 and 2030.
So I'll point out that, you know,
typically these days we think about sub-Saharan Africa.
This is where the most of the cases of HIV
and most people are dealing with HIV/AIDS.
But I'll also point out that, you know,
we don't talk about it much anymore,
but we still have huge numbers of people who are HIV positive
in the United States.
Well over a million, and the number continues to grow.
And it's one of these problems that is particularly bad
for underrepresented minority communities
that have limited access to healthcare.
Okay, so now the crash course in viruses.
What makes a virus a virus?
So, effectively, the simplest way to think about viruses
is that they make things called virions,
which are replicating nanoparticles.
So, at the nano scale, about 30 to 300 nanometers,
is kind of a common size of the virions
that we study and think about.
Virus came from the Latin for "poison."
It was first used in reference to rabies infection
in the 19th century.
Around that time, it was found that you could filter out
bacteria from animals who had things like rabies
or this chicken sarcoma virus that Howard Temin studied.
And you could still transmit serum and transmit the disease,
which meant that there was something smaller than bacteria
which we couldn't access, which was capable of causing disease.
Sort of a terrifying concept at the time.
And then, I'm a cell biologist or I like to think of myself
as a cell biologist, so the coolest thing
about viruses is that they're obligate, so they're parasites.
They're not capable of replicating on their own.
They have to find a cell in order to replicate.
They all have their own genomes and their own genes.
They make their own proteins and their own enzymes.
But they need cells or they can't do it.
So, this is the transmissible unit of a virus,
which is known as a virion.
Even though, in the newspaper, they'll show a picture of this
and they'll call it a virus,
remember to always correct them and say that's a virion.
The core of a virion is there's a genome so it's nucleic acid.
So, it's either DNA or RNA.
It can be double-stranded or single-stranded
depending on the virus.
There's every permutation on the planet
because there's so many viruses on the planet.
They all have different ways of operating.
This is the human papillomavirus that causes cervical cancer,
and other cancers can also,
different versions of it can cause warts on your skin.
And so papillomavirus has a DNA genome
that looks quite similar to the genome in our cells
that's wrapped up on these things called histones.
And it's packed in a capsid core, which is shown here,
and that protects the genome.
And the idea here is that this is Uber of the virus.
The virion can take the infection
from one cell to another.
So, if you want to understand the virus,
you have to understand the cell.
And viruses evolve to understand cells better than we ever could,
which makes them really good tools for research.
So the virion needs to get inside a cell.
So this is a depiction of an animal cell.
You see the nucleus here where the DNA is stored.
All the organelles in the cytoplasm that are there
for metabolism and processing proteins and making things work.
So, again, this concept where the viruses can't move,
generate energy, synthesize proteins outside the cell.
This is an age old debate over whether viruses are alive or not
because if this guy is on its own, it can't replicate.
It doesn't have everything that it needs.
In the context of a cell, some people argue
that a virus is alive, but you kind of end up
with this metaphysical concept of what is--
If it's really a living organism
or some other kind of organism.
So, what we've learned, especially with
new sequencing technologies, is that there are
an insane number of viruses on the planet.
So every virus needs a cell, and the world is full of cells.
So we're made of cells.
Plants are made of cells.
The soil is full of cells.
The ocean is massively full of cells.
It's just teeming with bacteria and other microbes.
And every one of those is potentially a host
for a different type of virus.
So it's now predicted that there are at least 100 million
different viruses on the planet.
Most infect bacteria in the ocean, and a recent realization
is that these infections of bacteria are actually involved
in a huge amount of nutrient turnover on the planet.
So it'll probably play very important roles in terms of
maintaining the viable ecosystem for the beautiful planet
that we live on.
In mammals, there are at least 320,000 different viruses
currently predicted.
And I mentioned this earlier, we know that there's at least
150 viruses that infect humans.
Not all of them cause diseases.
Some of them might actually help prevent diseases.
So it's a complicated world when it comes to viruses.
And this is--
I saw Jean-Yves walk in,
who is Jean-Yves Sgro
who has worked for the IMV in the Biotech Center
and has done all these amazing illustrations
of different viruses capsids and different virus structures,
which are accessible at this great website
called Virus World.
So if you get a chance, check it out.
These are some examples of the beautiful structures
that viruses come in.
Many of them are icosahedral in structure and spherical.
Many of them end up making what we call
spherical or filamentous nucleocapsids, which are linear.
There's every sort of shape and size that you can imagine.
And then on top of that, beyond the protein shell
and the genome, you can get all these accessories.
So some of the viruses have tails and spikes.
Many of the viruses that we're most concerned about,
Influenza, Ebola virus, HIV,
they have a lipid envelop.
so they steal some lipid from the surface of the cell
and surround themselves.
They add an extra layer of protection on top of the protein
that protects their genome.
So there's HIV.
It has a beautiful protein conical core
that coats two RNA genomes on the inside.
And then that's surrounded by a lipid.
And then, this is Ebola, which has this
long filamentous nucleocapsid surrounding an RNA genome,
but it's also wrapped in a lipid.
So, again, a huge amount of diversity
in different evolutionary strategies
that viruses have adopted to do what they do.
Okay, so what happens in the cell?
So I'm going to use Ebola as an example.
This is an image from a relatively recent review
on Ebola replication.
And, basically, what needs to happen, viruses,
they have relatively small genomes
since they're much smaller than cells.
So they have enough to replicate themselves, but everything else
has to come from the cell.
The first step is delivery.
So, for Ebola, these first four steps over here are delivery.
It's going to bind to a cell.
It's going to be taken up into the cell, and it's going
to find a way to get into the cytoplasm where it can access
all the enzymes that it needs to replicate.
Two is decoding, where the viral mRNAs--
So the genes in the virus make messenger RNAs
that are made into viral proteins to make new viruses.
And then, number three is the replication.
So, here we see protein synthesis
and things starting to come together.
The genomes are being replicated down here, step five.
And then, finally, everything has to come back together
in kind of this symmetrical process, make a new virus,
or new virion, sorry, and then, move on to the next cell.
So, viruses are very specific
in terms of the cells that they can infect.
They've adapted to certain cells.
That's why we don't--
Your dog might get a canine parvovirus,
but it won't be able to infect you
because you don't have the right cells for that virus.
And all viruses must involve a strategy
to move from host to host.
Some use blood products.
Some will-- Some prefer sneezes and door handles.
And then, within the tissues,
they have to have ways that they can circulate
in order to make enough copies to move on to the next person.
Okay, and then, I really like this other point
that a lot of viruses really ravish their cells.
So they're kind of
smash and burn.
They go into the cell, they replicate, they get out,
and they trash the place.
And a lot of double-stranded RNA viruses do this and also
positive-strand RNA viruses.
And I make this point because
for HIV, that's not really the case.
HIV, because it integrates its DNA into the genome,
it really wants to keep the cell happy
because it's going to be its home for a while.
And this is especially true, this is why we can't get rid of
HIV because once you're infected with the HIV,
it inserts its genome
into the cell forever,
and it hides out in those cells
so that even if you're on drugs, if you ever go off drugs,
there's going to be a few cells that are latently infected or
persistently infected, and then the virus will come raging back.
So, in terms of Madison real estate,
some people are more invested in their homes than others.
So, we have these smash and burn type viruses and the others that
are very committed to keeping the cell happy and healthy.
And then that has consequences for the pathogenesis.
Okay, so seeing is believing.
How do we see the viruses?
So, if you look at your hand, there's a bunch of cells there,
but you can't really see them.
You can see them, but they're all stitched together.
You can't see an individual cell unless you have a microscope.
It's too small.
So an average cell is probably about 10 microns in diameter.
Bacterium is about tenfold smaller than that.
About a micron.
And then, a typical virus
is about 10 times smaller than that.
So we can't see individual cells in our hands, in our saliva,
anywhere.
Kind of the exception would be eggs,
which are really big cells.
But the-- We can't see most bacterium
unless we have a microscope.
And then viruses are a severe challenge beyond that.
So how do we deal with that?
Traditionally, the way that we've studied viruses,
especially up until the 1980s, was using electron microscopy,
where the idea is we had technology, and some of this was
actually developed by Paul Kaesberg in the IMV, where we
could take viruses, or what we thought were viruses, and put
them on to a very thin grid, coat the grid with metal,
and then, bombard the sample with electrons.
And whatever light got through could then be detected, or
whatever electrons got through could be detected, and then
leave an image of what's there.
So that's how the viruses were originally detected and
characterized using the electron microscope, and you could get
resolution data to 120 nanometers.
This is the T2 bacteriophage,
which is a famous virus of bacteria.
You can see it looks like a lunar lander module.
So the genomes up in this capsid shell on top--
I hit the button.
And then there's this long syringe-like extension or tail,
and then it's got these little landing pads that it uses to
latch onto the bacteria and inject its nucleic acid.
It's almost designed like a syringe.
This is tobacco mosaic virus, one of the most famous plant
virus early viral model systems.
And it actually makes long helical capsids.
The capsids that are about 300 nanometers.
This is one of our images of HIV coming out of a cell.
So this is human cell making envelope HIV particles.
You can see the tiny little conical capsid in the interior
and the lipid envelop on the outside.
And then, recently, in the last 10 to 15 years, we've made huge
advances using a technique called cryo-electron microscopy
with tomography, or cryo-EM.
And the idea here is that you can make a bunch--
One, you can freeze the samples
instead of using harsh fixatives,
and you can maintain very good structure of viruses.
So you can maintain the lipids and the proteins,
keep them really happy,
and then you slice them up very carefully,
put them on an EM grid,
and you take a picture of each one of the individuals.
So it's like slicing up an apple.
You take a picture of each individual slice
and you turn it slowly in the beam
so that you get a whole bunch of different images
from different angles of that apple slice.
And then you can computationally put them all back together and
actually get a three-dimensional image of what's there.
And this has gotten so good now that the detectors can now
achieve single nanometer scale with some virus particles.
So some of the structures would be down to 2.6 angstroms which
used to be the only way we could get that kind of resolution
is with crystal structures.
So it's an exciting time for EM, and it continues to advance even
though it's a very old school technique.
All right, so, in the '80s, people started coupling fast
cameras with microscopes and moved into the age of time lapse
video microscopy.
And this is my favorite thing.
So, we finally get to a viral video.
[laughter]
So, this is a movie that I did with Kelly Waters and Ann
Palmenberg, who study human rhinovirus A in this case,
which causes the common cold.
And the idea here is that
each one of these individual blips is a cell.
So these are HeLa cells from Henrietta Lacks
that we use quite frequently for our research.
And we're going to infect them with the rhinovirus
and see what happens.
And so this is about 15 hours of imaging.
And what you can see is the cells are not very happy.
So this is a smash and burn virus.
This is a virus that does not care about itself for very long.
It just wants to make copies of itself, make the cell explode,
and release new copies of the virion.
So we can't see the virions.
They're too small, but we can see what happens to the cells.
And now, you can imagine this is what's going on in your lungs
every single time that you have a cold.
So, not a very nice virus.
And then, I really love this movie.
This is from Paul Friesen, who studies Baculovirus.
This is an insect virus.
I'm glad it doesn't infect humans because what it does is
it basically-- It causes caterpillars to melt.
It's really ferocious.
Its replication cycle is that it will actually reprogram
the caterpillar to climb to the top of a tree.
It will make the caterpillar melt, and then it'll drip down
onto the bottom leaves and then other caterpillars will eat it.
And that's how it moves from one caterpillar to the next.
It's absolutely insane.
So these are insect cells taken from drosophila, fruit flies,
and they're infected with Baculovirus.
And this is, I think, yeah, 24 hours of imaging.
And you can see what the Baculovirus does to the cells,
which is extraordinary.
So the cells are moving around.
You can kind of see a big sphere in the middle.
That's the nucleus.
And they start to bleb.
That's a sign that cells are getting sick, and they're
thinking about dying.
And then we're about 12 hours now.
Whoops.
Oh, man. Now I've got to restart the whole thing.
I can cut to chase.
And the virus starts cranking out protein like crazy.
And Baculovirus actually turn out to be a wonderful tool
for making protein for biotechnology purposes
because it completely hijacks cells,
uses all the resources in the cell to do its own bidding.
And what you see here are huge--
These are called
occlusions of viral capsid proteins in the interior.
They make these big and remarkable cubes
in the interior of the cell.
And you can see at the end of the movie, you know,
the cell looks nothing like it did at the beginning,
and it's pretty drastic transition.
Okay, so HIV, as I mentioned, is not so disruptive.
So you don't learn much from studying HIV
just with a light microscope.
You've got to have a trick in order to
put a label into the virus so you can actually see it.
So I've kind of shown you this earlier, but the basic
30-second life cycle of HIV is that it's a virus
that has two copies of an RNA genome,
has this lipid envelop,
it recognizes a receptor on the surface of select cell types,
and releases the capsid into the cell.
This is Howard Temin's discovery is that the RNA genome,
which is red, gets turned into blue DNA,
shown here, and then that
gets taken up into the nucleus and stuck into our genome.
And then after that it really pretends to be a cellular gene.
So this is a really clever virus.
It just acts like all the rest of our genes.
It tells-- It uses our enzymes to make messenger RNAs
that are then taken out into the cytoplasm to make new proteins,
and then those proteins make new virions
and they go on to infect other cells.
Okay, so how do we study HIV?
And here the key breakthrough was in the '90s
where it was identified by a few different groups
that these jellyfish and other organisms in the ocean
had fluorescent tendencies.
And a few of the groups were able to isolate the genes
that made them fluoresce.
And the most famous one
is this one called green fluorescent protein.
Most of the work on this was done by Roger Tsien,
who won the Nobel Prize with two other groups
for this discovery.
And their clever idea was, well, if we could isolate this
fluorescent protein, we could attach it to whatever we want,
and then we could put it under a microscope
and we could do just what the jellyfish does,
is we could use that fluorescent protein to detect light
and then emit a different wavelength,
which is the essence of fluorescence,
and we could track that protein in the interior of the cells.
And this would open up all of cell biology because
now we could actually see what's going on inside a cell,
not just watching cells die.
So when I was in grad school,
we started engineering fluorescent viruses.
There were a few other groups that were doing this as well,
but I think we were the best.
[laughter]
But the idea here was if we could make that capsid,
so that cone in the center of HIV or other retroviruses,
green, for example, and use other fluorescent proteins.
So by the time that I was in grad school, there was a whole
rainbow of different fluorescent proteins that could be used,
so you could actually make two- or three-color viruses.
We could make a fluorescent envelop.
Then we could actually look inside cells,
and we could see how the viruses came out of the cells,
how they went into the cells,
and how they moved from one cell to another.
So, that's what we set out to do.
And this work was done with Walther Mothes
at Yale University when I was a graduate student.
So we engineered murine leukemia virus,
which is a virus very similar to HIV.
It has a very similar lifestyle.
It's also a retrovirus.
We did the same thing for HIV,
but most of our emphasis was on MLV.
It was a bit safer and easier to work with
as a model.
And we fused the capsid protein, which is called Gag,
which makes this shell in the center of the retrovirus
to green fluorescent protein.
And then there's a glycoprotein that the virus makes
that sticks on the outside.
So it's the spike protein.
We made that red.
We found a place to insert the fluorescent protein
that wouldn't screw up the virus.
And then, actually, in the back--
So, we could spin down those virions
that were secreted from cells
and make big tubes full of these fluorescent viruses
that we could then throw on cells.
So this is work from a post doc in Walther's lab,
Mike Lehmann.
One of the early cool things that we found was
this phenomenon called "virus surfing,"
where this is an uninfected cell, which is green.
So, it's fluorescent green so you can see it.
And it turns out,
when you start looking closely at fluorescent cells,
they're covered in these actin-rich protrusions.
So, you know, actin is the protein that runs our muscles,
but it's also used in cells
to guide a lot of motility in different functions.
So you see these long fibers sticking out.
Those are called filopodia,
and one of the things that we characterize,
when you added virions to cells,
they would bind to these actin-rich filopodia
and move inward.
And we can show by electron microscopy that
the virions are actually on the outside of the filopodia.
So they were actually surfing along the outer surface.
That's why we call it surfing.
And then, you know, kind of
our overarching model for why the viruses did this
with several additional studies
was that they would use these filopodia to get in towards--
Retroviruses want to get their genomes toward the nucleus.
So this allowed them to directionally move
from the outer space towards the inner space.
And we can see them co-localizing with these things
called endosomes, which are vesicles that take things
from the surface of the cell into the interior
in order to direct things inward.
So, I never published this but this was one of my achievements
where I think, you know,
I was probably the first person to ever see a retrovirus
actually budding and forming in real-time.
So these are individual virus particles forming
on the surface of a cell.
You can see the cell moving and kicking around.
The green signal is the Gag protein, and every now and then
it all coalesces together to form a little dot.
And you can see an example of that here.
And then you can see there's an example of some other virions
stuck on the surface.
And there's one, when it loops around again, about here
that pinches off and floats away to go infect another cell.
So, anyway, this was a useful tool for sort of
starting to understand how fast viruses were made,
how they got out of the cell, where it happened.
It was pretty clear from these types of movies
that it was happening at the surface plasma of the cell.
At the time that wasn't known.
And how they get into the interior of the cells.
And the other one that we were very interested in is how do
viruses move from cell to cell.
So, you know, you guys are comfortable
with the virion idea now,
and it turns out there's multiple ways
that virions can move from one cell to another.
There's what we call the cell-free mode, which, you know,
with an HIV infection probably happens in the blood stream.
There's lots of little virions that are moving around
and circulating and looking for new host cells.
So they can float through space and then infect a new cell.
But then there's also this notion that in dense tissues,
if you have a cell that's infected with a virus,
such as HIV,
and it encounters a cell that's uninfected, the two cells
can actually interact to form intimate linkages,
which we call virological synapses.
And at these sites of contact is very efficient for infection
to move from one cell to another.
So we set up some systems to try to visualize this in real-time.
And here's my favorite movie ever.
So what you see here is an uninfected cell.
Here's an infected cell.
It's making little red murine leukemia virus dots.
And when the two cells interact with each other,
they grab onto each other.
You see the little dots form at the site of contact.
And then they go running over from one cell to another.
So this entire movie is about 30 minutes,
but it almost looks like a machine gun.
The virions are being shot over to the uninfected cell.
And then this one is kind of dramatic.
It's a bit bright up here.
I don't know if I can fix the light,
but I didn't have any instructions.
[laughs]
But anyway, this was, in terms of folk stories,
this was a nice movie because it shows the--
I lost my cursor.
Oh well.
It shows the--
It shows an infected cell making green viruses
in the center with two uninfected cells in either
direction sort of pumping viruses in both directions.
And if you're looking for-- Here's my cursor.
Okay.
If you're looking for a good date movie, there were actually-
a bunch of our movies were used as the intro
to this movie about HIV in the African American community.
It's a murder mystery by Bill Duke in the intro credit.
So that was one of my most exciting achievements.
[laughter]
I'm in the movie database with the credits.
So, check out "Cover," directed by Bill Duke.
Okay, so now we're working on, since we've come to Madison,
when I did my post doc, I didn't do any imaging, or very little,
you know?
I learned all sorts of other techniques.
But I worked a lot on RNA trafficking and HIV gene
expression, and everything was very focused on HIV.
So, when I got here, the thought was that technology
has progressed to the point where we now have microscopes
where we can-- A lot of those movies I showed you
were half an hour, two hours.
Now, we can keep cells alive for days, and we have automated
stages where we can look at 24 different conditions
for three or four days.
We can look at multiple rounds of infections.
We can look at how the cells are interacting.
We can look at six different colors because of all these
different fluorescent proteins.
And we can use the computer to start to make
these very elaborate models for what's going on.
So, I'm getting late
so I'm going to go through this relatively quickly.
But one of the systems that we set up was we wanted to
understand HIV gene expression, how we make a virus particle,
and kind of the overarching goal to this is that we don't have
any drugs that shut off HIV virion production.
All the drugs that we have in the clinic
kill the virions after they've been made.
So if we could figure out ways
to shut off making new virus particles, that would be useful.
And we know a lot about how this works, but not enough.
Still a lot of questions.
So we set up this system where we could see HIV genomes
in the nucleus using one color.
So we can make green RNAs that are going to be exported
from the nucleus into the cytoplasm.
They're going to encode a blue Gag protein.
I brought this one up earlier.
That's the protein that makes the capsid shell
that makes the virion.
So this is a budding virion at the surface of the cell.
And then we're going to use this red protein that I haven't
introduced yet, which is called Rev, which is an activator of--
It turns on gene expression for the virus.
So we had a system where, if we put in the red protein,
that would take the green genome out of the nucleus.
That would make the blue protein,
and then the whole virion would get made at the cell surface.
So we wondered if we could model this using three colors.
So we made this virus, which we called three-colored visible
HIV, and then this is what it looked like in the cell
when we could finally figure out a way to image for 24 hours
without killing the cell.
In order to do that, you need cells that are very cooperative
and that don't move and very hardy and don't mind being
blasted with light for long periods of time.
And again, HeLa cells are very good for this.
So, what you see in this movie is that, at the beginning,
we're starting to see the red protein,
and that's the protein that's turning on gene expression.
The green signal that you're seeing in the center circle
is individual genomes inside the nucleus.
And then, over time, that green signal
is going to move into the cytoplasm,
and that's where translation occurs and proteins are made.
So we're seeing nuclear export of messenger RNAs
and translation.
And then, at the end of it,
we start seeing bright blue and green dots,
which are new virions being made at the cell surface.
So, it worked great.
We can see the entire--
All the explosive events
that occurred during HIV virion assembly.
And, really, we're visualizing the central dogma.
We're seeing RNAs being made.
We're seeing them exported from the nucleus.
We're seeing translated to make protein.
And then we're seeing the proteins do something, which,
in this case, is make a virion.
And we've kind of set up this systems-based approach where we
can do these movies on thousands of cells simultaneously,
and then we ask the computer
to start to extract information from the movies.
And this is work led by Ginger Pocock,
with help from Jordan Becker in the lab.
And using advanced image analysis,
we can then extract all sorts of intimate details
about what's going on in each single cell
and then use that to build a model for how we think
that virus assembly and virus particle production works.
So I moved quickly through this, but this has allowed us to build
a spatial-temporal model for all these different aspects.
So, between zero to 15 hours,
we see genomes being made in the nucleus.
They get exported to the cytoplasm.
We can measure very carefully the rates of Gag synthesis.
And then we can see, in this movie, we can see
when virus particles start to be made very specifically.
And now we're using this for a lot of different things.
We're learning, using it to study
mechanistic aspects of the virus.
So, what cellular proteins and what viral proteins
make this whole thing work
and how can we perturb that in a productive way.
We want to set this up as a high content screening platform where
we could, you know, use drugs and not only know
if they're blocking HIV replication
but specifically at what stage are they blocking the pathway.
And we have great collaborators on campus to develop new image
analysis tools because this is really the future where we can
use imaging to extract as much information as possible
from movies, effectively, and tell us lots of things.
And these are just some additional fun viral videos.
So, in terms of understanding the regulation of this export
pathway, what you see here are HIV RNAs.
We've been testing different cellular factors, which we think
might be involved in the gene expression pathway.
And when I turn this on, you'll see the HIV red protein come up
in Rev, and that's the protein that turns on gene expression.
But we've also put in a protein that you can see that's called
Sam68, and when we do that it makes everything basically
explode out of the nucleus.
So we've accentuated this spatial nuclear export activity
that nobody's ever seen before.
And I'm very excited about this because it implies that--
We always thought that mRNAs in the nucleus
just trickle out of the pores.
But here they all move into a big focus.
We've also been able to use this system
to identify new activities.
So what you see here are two cells that are actively--
A cell that's dividing into two daughter cells.
So the red signal here is microtubules,
which form the spindles
that take the chromosomes into the two new cells.
And the green signal is the viral RNA,
and we found a specific viral element
that clumps RNAs very specifically onto microtubules.
And we honestly don't have any functional relevance for this,
but it's a pretty movie so we're trying to understand
why would RNAs want to go to the end of microtubules
in these sub-organelles called centrosomes.
And then the other thing that we're working on
that I'll finish with is the most important thing
is understanding how HIV spreads in tissues
and how it establishes long-term persistent infection.
So, you know, HIV is very good at hiding in dendritic cells
and tricking immune cells
to pass the virus on from one to the other.
So we've been trying to make these--
We've been trying to take a step back
and set up systems where we can make scenarios
that look like tissues and then mix cells together
that are infected and uninfected
and use fluorescent markers
in order to track the virus moving over time.
So what you see here, the red cells are infected with HIV
and the green cells are uninfected.
And they're moving, and we've developed software where we can
track how the cells interact, when they become infected,
all these different attributes of the infection system.
And then, hopefully, we can develop this into better systems
for finding ways to actually block the spread of infection.
This is just to show that we can measure stuff.
[laughter]
And by measuring these things, by making it quantitative, we
can come up with new models for how we think the system works.
So the quantification and the computational aspects
are very important.
And so, in terms of cell-cell spread,
our initial studies have allowed us
to develop this model for how we think
remodeling of the infected cell in red
allows it to basically grab on to uninfected cells
and then make them do their bidding.
So I'll summarize and just say that UW Madison
is a fantastic place to study viruses.
If you're into viruses, this is the place to be.
HIV/AIDS remains a huge global and local problem.
And hopefully I've convinced you that live cell imaging
is both fun and sometimes informative.
We've learned quite a bit about how viruses work
and how cells work.
And some of these discoveries have been relevant
to thinking about new therapeutic strategies.
And, again, I think in the future,
combining live cell imaging and
different fluorescent imaging based platforms
is going to be tremendously useful
with new statistics and new computational models
for setting up these model systems,
for understanding how viruses work,
the next generation of drug screenings
and even new clinical diagnostic tools.
And finally, the most important part
is the people who did the work.
So, in my lab, I showed work
from Jordan and Ginger,
who've done the--
Jordan's done a lot setting up the visual system.
Ginger is our image analysis guru.
Jay Gardner is working on the cell-cell transmission system.
And I'm grateful to everybody else in the lab.
We have fantastic collaborators on campus
doing a lot of different viruses
and imaging projects.
I especially emphasized
Paul Ahlquist and the Morgridge Institute for
their investment in virology and helping young faculty on campus.
These guys, Walther and Mike,
were my mentors who provided a lot of the ideas.
And then the people that make the research go.
So we have funding from the NIH,
the Shaw Scientist Program from the Greater Milwaukee Foundation
the Wisconsin Partnership Program,
and we just got money from WARF, UW2020,
to buy a new microscope.
So, we're incredibly grateful for all those contributions.
And I'll put this slide back up on there.
Make sure you "like" McArdle Laboratory for Cancer Research
on Facebook. [laughter]
And I'm very happy to take any questions.
[applause]